FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for hydrochlorothiazide filed by Exelan Pharmaceuticals Inc. (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Hypertension
• Nephrogenic Diabetes Insipidus

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)